Skip to main content
. 2022 Apr 13;9:863238. doi: 10.3389/fcvm.2022.863238

FIGURE 1.

FIGURE 1

Schematic representation of miRNA-based drug development. Adenovirus, adeno-associated virus (AAV), lentivirus particles, and liposomes are used to deliver miRNA mimics or antimiRs; miRNAs are investigated in vitro, in vivo, and ex vivo models to develop next-generation therapeutics for cardiovascular diseases. CMs, cardiomyocytes; EHTs, engineered heart tissues; hiPSCs, human induced pluripotent stem cells; I/R, ischemia-reperfusion; MI, myocardial infarction; TAC, transverse aortic constriction.